2024
DOI: 10.2147/ijn.s449388
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives

Yanjuan Song,
Jing Hu,
Chunlian Ma
et al.

Abstract: The development of numerous diseases is significantly influenced by inflammation. Macrophage-derived exosomes (M-Exos) play a role in controlling inflammatory reactions in various conditions, including chronic inflammatory pain, hypertension, and diabetes. However, the specific targets and roles of M-Exos in regulating inflammation in diseases remain largely unknown. This review summarizes current knowledge on M-Exos biogenesis and provides updated information on M-Exos' biological function in inflammation mod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 140 publications
0
1
0
Order By: Relevance
“…This mechanism by which immune cells can signal to the placental unit may aid responses to maternal inflammation and infection and thereby, serve to limit harm to the fetus. Indeed, researchers have highlighted that potential role of macrophage-derived exosomes as therapeutics for clinical translation ( 71 ). However, further work is needed to study their benefit at the maternal-fetal interface and in improving pregnancy outcomes.…”
Section: Receptor-mediated Endocytosis At the Maternal-fetal Interfacementioning
confidence: 99%
“…This mechanism by which immune cells can signal to the placental unit may aid responses to maternal inflammation and infection and thereby, serve to limit harm to the fetus. Indeed, researchers have highlighted that potential role of macrophage-derived exosomes as therapeutics for clinical translation ( 71 ). However, further work is needed to study their benefit at the maternal-fetal interface and in improving pregnancy outcomes.…”
Section: Receptor-mediated Endocytosis At the Maternal-fetal Interfacementioning
confidence: 99%